Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 2/2006

01-03-2006 | Original Article

A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis

Authors: O. Nadashkevich, P. Davis, M. Fritzler, W. Kovalenko

Published in: Clinical Rheumatology | Issue 2/2006

Login to get access
Metadata
Title
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis
Authors
O. Nadashkevich
P. Davis
M. Fritzler
W. Kovalenko
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1157-y

Other articles of this Issue 2/2006

Clinical Rheumatology 2/2006 Go to the issue

Original Article

Ankylosing spondylitis and undifferentiated spondyloarthritis in Kuwait: a comparison between Arabs and South Asians

Case Report

Heterotopic ossification of the supraspinatus tendon after rotator cuff repair: case report

Original Article

Evaluation of the turkish version of the bath ankylosing Spondylitis Patient Global Score (BAS-G)

Original Article

Association of systemic and thyroid autoimmune diseases

Case Report

Acute arthritis of carpal bones secondary to metastatic gastric cancer

Original Article

Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits